Low tumor burden follicular lymphoma: The state of the art.
Abstract Follicular lymphoma (FL) is the commonest indolent non‐Hodgkin lymphoma. Most patients present with advanced‐stage and are stratified by the Groupe d'Etude des Lymphomes Folliculaires (GELF) criteria into high or low tumor burden (LTB). Randomized trials in LTB FL demonstrated no overall survival advantage with immediate treatment compared to watchful waiting (WW). This led to the widespread practice of WW and the consideration of LTB FL as a single indolent continuum. However, LTB FL...